Healthcare provider profile · identity verified

Aloysius Yinug, M.D

Family Practice · STANWOOD, WA · NPI 1730183708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	567	192
Levothyroxine Sodium	Levothyroxine Sodium	368	114
Lisinopril	Lisinopril	343	116
Losartan Potassium	Losartan Potassium	309	101
Tamsulosin Hcl	Tamsulosin Hcl	281	100
Amlodipine Besylate	Amlodipine Besylate	268	90
Omeprazole	Omeprazole	244	93
Metoprolol Succinate	Metoprolol Succinate	234	79
Trazodone Hcl	Trazodone Hcl	172	54
Albuterol Sulfate Hfa	Albuterol Sulfate	160	74
Pantoprazole Sodium	Pantoprazole Sodium	159	50
Potassium Chloride	Potassium Chloride	156	51
Simvastatin	Simvastatin	156	49
Gabapentin	Gabapentin	155	64
Hydrochlorothiazide	Hydrochlorothiazide	154	60
Metformin Hcl	Metformin Hcl	152	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	137	86
Rosuvastatin Calcium	Rosuvastatin Calcium	132	47
Furosemide	Furosemide	124	50
Alprazolam	Alprazolam	120	41
Zolpidem Tartrate	Zolpidem Tartrate	116	38
Allopurinol	Allopurinol	95	29
Atenolol	Atenolol	93	29
Sertraline Hcl	Sertraline Hcl	89	31
Metformin Hcl Er	Metformin Hcl	85	32
Tramadol Hcl	Tramadol Hcl	82	28
Finasteride	Finasteride	74	25
Oxycodone Hcl	Oxycodone Hcl	71	36
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	68	49
Diclofenac Sodium	Diclofenac Sodium	65	20
Prednisone	Prednisone	62	42
Ozempic	Semaglutide	60	17
Duloxetine Hcl	Duloxetine Hcl	59	19
Methocarbamol	Methocarbamol	58	28
Bupropion Xl	Bupropion Hcl	56	19
Jardiance	Empagliflozin	56	16
Lorazepam	Lorazepam	56	16
Metoprolol Tartrate	Metoprolol Tartrate	56	19
Tizanidine Hcl	Tizanidine Hcl	56	22
Triamcinolone Acetonide	Triamcinolone Acetonide	54	38
Fluticasone Propionate	Fluticasone Propionate	53	25
Alendronate Sodium	Alendronate Sodium	52	14
Baclofen	Baclofen	52	suppressed
Glimepiride	Glimepiride	52	18
Famotidine	Famotidine	49	21
Valacyclovir	Valacyclovir Hcl	49	21
Citalopram Hbr	Citalopram Hydrobromide	48	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	16
Lovastatin	Lovastatin	48	15
Meloxicam	Meloxicam	48	20
Clopidogrel	Clopidogrel Bisulfate	47	20
Fluoxetine Hcl	Fluoxetine Hcl	46	14
Clonazepam	Clonazepam	45	11
Buspirone Hcl	Buspirone Hcl	44	14
Glipizide Er	Glipizide	44	15
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	15
Pravastatin Sodium	Pravastatin Sodium	43	14
Telmisartan	Telmisartan	42	19
Estradiol	Estradiol	41	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	13
Carvedilol	Carvedilol	40	16
Doxazosin Mesylate	Doxazosin Mesylate	40	11
Spironolactone	Spironolactone	40	18
Quetiapine Fumarate	Quetiapine Fumarate	39	12
Valsartan	Valsartan	39	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	15
Mirtazapine	Mirtazapine	35	11
Topiramate	Topiramate	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	26
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Eliquis	Apixaban	33	16
Ezetimibe	Ezetimibe	32	14
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Acyclovir	Acyclovir	30	11
Hydralazine Hcl	Hydralazine Hcl	30	11
Irbesartan	Irbesartan	30	11
Pregabalin	Pregabalin	30	suppressed
Celecoxib	Celecoxib	28	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Warfarin Sodium	Warfarin Sodium	26	13
Azithromycin	Azithromycin	25	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	15
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Amoxicillin	Amoxicillin	24	15
Meclizine Hcl	Meclizine Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Diazepam	Diazepam	22	suppressed
Mupirocin	Mupirocin	22	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Torsemide	Torsemide	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Cephalexin	Cephalexin	20	14
Clotrimazole	Clotrimazole	20	suppressed
Colchicine	Colchicine	20	12
Loperamide	Loperamide Hcl	19	suppressed
Glipizide	Glipizide	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Nitroglycerin	Nitroglycerin	18	15
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Fluconazole	Fluconazole	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Valproic Acid	Valproic Acid	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error